- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05632692
Menthol Mouth Rinsing and Performance Responses of Elite Football Referees in the Heat
Menthol Mouth Rinsing and Performance Responses of Elite Football Referees in the Heat: a Randomized Crossover Trial
Ten male football referees will be recruited to perform two intermittent football protocols , separated by at least 7 days (wash-out period). After passing the eligibility criteria, the participants will be randomly assigned, according to a computer-generated allocation schedule, to 1 of 2 beverages sequences: (1) intervention - menthol solution 0.01% (room temperature) and (2) placebo - noncaloric berry-flavoured solution (room temperature). The participants will be provided with one of the 2 beverages before warm-up (pre-cooling) and at the half-time (per-cooling). The trials will follow a randomised counterbalanced crossover design, blinded to the participants, and will take place in indoor facilities, where WBGT exceed 30◦C, at the same time of the day, to control for circadian variations. Each trial involves an exercise protocol (SAFT-90), lasting 90 minutes, separated into two 45-minute parts. The first half will be preceded by a warm-up and the second half by a 15-minute break.
The results of this study are expected to determine whether mouth rinsing a menthol solution, before a football exercise protocol performed in the heat, will help to alleviate physiological strain and improve performance parameters, comparing to a non-cooling strategy, in elite male football referees. Thus, we can be closer to defining nutritional strategies of internal cooling, that will be an advantage for the performance of the football referees, concretely in the competitions carried out under adverse environmental conditions.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male football referees aged over 18 and under 45 years;
- With normal weight (BMI ≥ 18.5 and ≤ 24.9 kg/m2);
- Availability to participate in the introductory meeting, familiarization session and 2 experimental sessions;
- Ability to read and sign the informed consent.
Exclusion Criteria:
- Under the influence of any medications that may affect urinary parameters, thermoregulation mechanisms, circulatory system, thyroid and pituitary function or metabolic status;
- Injury, diabetes, autoimmune disease, cardiovascular disease or obstructive disease of the gastrointestinal tract (e.g., diverticulitis, inflammatory bowel disease);
- Schizophrenia, bipolar disorder or other psychotic disorders;
- Eating disorders;
- MRI scans scheduled within 48 hours after familiarization session or any of the experimental trials.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
A menthol solution is going to be formulated by crushing and dissolving one noncalorific menthol candy drop (15 mg) in 150 ml of warm water, in order to obtain a solution with a concentration of 0.01%.
Prior to use, solutions are going to be aliquoted for mouth rinse and warmed at room temperature.
Then, it will be served to each participant on individual bottles in a total dose of 75 ml before exercise and 75 ml during exercise.
|
Menthol application, through oral solutions, stimulates the mandibular and maxillary branches of the trigeminal nerve (which are predominantly responsible for detection of temperature and nociceptive stimuli across the face and within the oral cavity) and has consistently shown to improve thermal comfort and decrease thermal sensation, which are thought to modulate perceived exertion to improve performance in the heat.
|
|
Placebo Comparator: Placebo
A placebo beverage is going to be prepared using noncaloric berry-flavored sweetener consisting of sucralose candy drops, which will be crushed and dissolved in 150 ml of warm water.
Prior to use, solutions are going to be aliquoted for mouth rinse and warmed at room temperature.
Then, it will be served to each athlete on individual bottles in a total dose of 75 ml before exercise and 75 ml during exercise.
|
Menthol application, through oral solutions, stimulates the mandibular and maxillary branches of the trigeminal nerve (which are predominantly responsible for detection of temperature and nociceptive stimuli across the face and within the oral cavity) and has consistently shown to improve thermal comfort and decrease thermal sensation, which are thought to modulate perceived exertion to improve performance in the heat.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate change
Time Frame: A change in heart rate from baseline (immediately before exercise) to each 15-minute block of the exercise protocol will be assessed.
|
Heart rate is a physiological parameter of performance and will be measured through HR monitors (Polar H10 Heart Rate Sensor, USA).
PolarH10 can accurately measure mean HR and low-frequency oscillations (up to 0.15 Hz) of HR at rest and during exercise.
|
A change in heart rate from baseline (immediately before exercise) to each 15-minute block of the exercise protocol will be assessed.
|
|
Sweating rate at the first half
Time Frame: Sweating rate is going to be calculated at the end of the first half of the exercise protocol (after 45 min of exercise)
|
Sweating rate is a physiological parameter of performance and is going to be calculated recurring to the following equation : SR= (Pre exercise body weight - postexercise body weight + fluid intake - urine volume)/(exercise time in hours).
|
Sweating rate is going to be calculated at the end of the first half of the exercise protocol (after 45 min of exercise)
|
|
Sweating rate at the second half
Time Frame: Sweating rate is going to be calculated at the end of the second half of the exercise protocol (after 90 min of exercise)
|
Sweating rate is a physiological parameter of performance and is going to be calculated recurring to the following equation : SR= (Pre exercise body weight - postexercise body weight + fluid intake - urine volume)/(exercise time in hours).
|
Sweating rate is going to be calculated at the end of the second half of the exercise protocol (after 90 min of exercise)
|
|
Core temperature change
Time Frame: A change in core temperature from baseline (immediately before exercise) to each 15-minute block of the exercise protocol will be assessed
|
Core temperature is a physiological parameter of performance and can be accessed using a telemetric pill ingested 30 minutes prior the start of the exercise (BodyCap®, France).
Due to the good measuring accuracy, the ability to measure in field-based situations and the non-invasive character of this temperature measurement method, the ingestible telemetric temperature pill is suitable to assess core temperature during exercise
|
A change in core temperature from baseline (immediately before exercise) to each 15-minute block of the exercise protocol will be assessed
|
|
Ratings of perceived exertion (RPE)
Time Frame: RPE is going to be accessed at the end of the exercise protocol.
|
RPE is a subjective psychological/perceptual parameter that impacts performance and will be recorded through CR-10 Borg scale that goes from 0 ("rest") to 10 ("maximal effort").
|
RPE is going to be accessed at the end of the exercise protocol.
|
|
Thermal comfort (TC) change
Time Frame: A change in TC from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.
|
TC is a subjective psychological/perceptual parameter that influences performance and is going to be accessed according to a 6-point scale from to -3 ("very uncomfortable) to 3 ("very comfortable").
|
A change in TC from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.
|
|
Thermal sensation (TS) change
Time Frame: A change in TS from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.
|
TS is a subjective psychological/perceptual parameter that impacts performance and will be recorded with a 9-point scale from -4 ("very cold") to 4 ("very warm").
|
A change in TS from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.
|
|
Perceived thirst (PT) change
Time Frame: A change in PT from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.
|
PT is a subjective marker of hydration status and will be evaluated recurring to a 7-point scale from 1 ("not thirsty at all") to 7 ("very, very thirsty")
|
A change in PT from baseline (immediately before intervention) to after intervention and to each 15-minute block of the exercise protocol will be assessed.
|
|
Physical performance change
Time Frame: A change in each physical performance indicator from baseline (immediately after the warm-up) to each 15-minute block of the exercise protocol will be assessed
|
Physical performance responses will be measured using 100 Hz accelerometery, with Sonda 4.0 software (StatSports®, UK) to estimate total distance, sprint distance, accelerations and decelerations number
|
A change in each physical performance indicator from baseline (immediately after the warm-up) to each 15-minute block of the exercise protocol will be assessed
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hydration status before
Time Frame: Hydration status is going to be recorder at baseline (pre-exercise)
|
Hydration status is going to be assessed recurring to urine test strip (Combur10 Test M, Roche) and Urisys 1100® analyser (Roche, Switzerland).
|
Hydration status is going to be recorder at baseline (pre-exercise)
|
|
Hydration status after
Time Frame: Hydration status is going to be recorder at the end of the exercise protocol
|
Hydration status is going to be assessed recurring to urine test strip (Combur10 Test M, Roche) and Urisys 1100® analyser (Roche, Switzerland).
|
Hydration status is going to be recorder at the end of the exercise protocol
|
|
Ad libitum fluid intake at the first half
Time Frame: Ad libitum fluid intake is going to be assessed at the end of the first half of the exercise protocol (after 45 min of exercise)
|
Fluid intake is going to be recorded via the measurement of mass change of the individual bottles provided to the referees at the warm-up and at the end of the session, to the nearest 0.1 ml (Seca, Hamburg, Germany).
|
Ad libitum fluid intake is going to be assessed at the end of the first half of the exercise protocol (after 45 min of exercise)
|
|
Ad libitum fluid intake at the second half
Time Frame: Ad libitum fluid intake is going to be assessed at the end of the second half of the exercise protocol (after 90 min of exercise)
|
Fluid intake is going to be recorded via the measurement of mass change of the individual bottles provided to the referees at the warm-up and at the end of the session, to the nearest 0.1 ml (Seca, Hamburg, Germany).
|
Ad libitum fluid intake is going to be assessed at the end of the second half of the exercise protocol (after 90 min of exercise)
|
|
Blood lactate levels before
Time Frame: Blood lactate levels are going to be recorded before the start of the exercise protocol
|
Blood lactate levels will be measured recurring to a Blood Lactate Meter (Lactate Pro 2, Arkray, U.S.A).
|
Blood lactate levels are going to be recorded before the start of the exercise protocol
|
|
Blood glucose levels before
Time Frame: Blood glucose levels are going to be recorded before the start of the exercise protocol
|
Blood glucose levels will be measured recurring to a Glucometer (FreeStyle Precision Neo, Abbott Laboratories, U.S.A).
|
Blood glucose levels are going to be recorded before the start of the exercise protocol
|
|
Blood glucose levels after
Time Frame: Blood glucose levels are going to be recorded immediately after the end of the exercise protocol
|
Blood glucose levels will be measured recurring to a Glucometer (FreeStyle Precision Neo, Abbott Laboratories, U.S.A).
|
Blood glucose levels are going to be recorded immediately after the end of the exercise protocol
|
|
Blood lactate levels after
Time Frame: Blood lactate levels are going to be recorded immediately after the end of the exercise protocol
|
Blood lactate levels will be measured recurring to a Blood Lactate Meter (Lactate Pro 2, Arkray, U.S.A).
|
Blood lactate levels are going to be recorded immediately after the end of the exercise protocol
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20/2021/CEFCNAUP/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.